SHOPIFY INC - CLASS A
SHOPNASDAQ🏆 #61 by market capEarnings Nov 3US Equity
$152.61▼ $2.53 (−1.66%)
Market closed · at close1h—
24h▼ 1.7%
7d▲ 5.8%
14d▲ 18.2%
30d▲ 22.3%
1y▲ 2.2%
🏦Market Cap
$198.03B
Mid Cap
📈Revenue Growth (YoY)
+32.5%
High Growth
📊Gross Margin
47.8%
Healthy
💵FCF Margin
17.7%
Healthy
⚖️P/S Ratio
15.0x
Expensive
Otter Score
47
Weak
📊
Analyst Ratings
Price
$152.61
Total
64
Raised
13
Lowered
11
Avg PT
$168.38
| Institution | Action | Rating | Date |
|---|---|---|---|
Barclays | Reiterated | Equal Weight | 2026-08-06 |
Citizens | Reiterated | Market Outperform | 2026-08-06 |
Cantor Fitzgerald | Reiterated | Neutral | 2026-08-06 |
Goldman Sachs | Reiterated | Buy | 2026-08-06 |
Truist Securities | Reiterated | Buy | 2026-08-06 |
Wedbush | Reiterated | Outperform | 2026-08-06 |
Evercore ISI Group | Reiterated | Outperform | 2026-08-06 |
Benchmark | Reiterated | Buy | 2026-08-06 |
Citigroup | Reiterated | Buy | 2026-07-24 |
Rothschild & Co | Downgraded | Buy → Neutral | 2026-07-21 |
Jefferies | Upgraded | Hold → Buy | 2026-07-13 |
Stifel | Upgraded | Hold → Buy | 2026-07-10 |
DA Davidson | Reiterated | Buy | 2026-05-06 |
Canaccord Genuity | Reiterated | Buy | 2026-05-06 |
Wells Fargo | Reiterated | Overweight | 2026-05-06 |
RBC Capital | Reiterated | Outperform | 2026-05-06 |
UBS | Reiterated | Neutral | 2026-05-06 |
Needham | Reiterated | Buy | 2026-05-05 |
Mizuho | Upgraded | Neutral → Outperform | 2026-02-12 |
BMO Capital | Reiterated | Outperform | 2026-02-12 |
Scotiabank | Upgraded | Sector Perform → Sector Outperform | 2026-01-08 |
Wolfe Research | Downgraded | Outperform → Peer Perform | 2026-01-06 |
JP Morgan | Reiterated | Overweight | 2025-11-05 |
CIBC | Reiterated | Outperform | 2025-11-05 |
Morgan Stanley | Reiterated | Overweight | 2025-11-05 |
Keybanc | Reiterated | Overweight | 2025-10-30 |
Oppenheimer | Reiterated | Outperform | 2025-10-28 |
JMP Securities | Reiterated | Market Outperform | 2025-08-07 |
Loop Capital | Downgraded | Buy → Hold | 2025-07-22 |
Baird | Reiterated | Outperform | 2025-07-14 |
Piper Sandler | Reiterated | Neutral | 2025-02-12 |
MoffettNathanson | Reiterated | Neutral | 2024-11-26 |
Redburn Atlantic | Upgraded | Neutral → Buy | 2024-09-17 |
Deutsche Bank | Reiterated | Buy | 2024-08-08 |
Roth MKM | Reiterated | Buy | 2024-08-08 |
B of A Securities | Upgraded | Neutral → Buy | 2024-07-16 |
TD Securities | Reiterated | Hold | 2024-05-09 |
Exane BNP Paribas | Downgraded | Neutral → Underperform | 2024-01-18 |
DZ Bank | Downgraded | Hold → Sell | 2023-12-12 |
Credit Suisse | Reiterated | Neutral | 2023-07-14 |
Atlantic Equities | Downgraded | Overweight → Neutral | 2023-05-09 |
National Bank Of Canada | Reiterated | Outperform | 2023-05-05 |
CFRA | Upgraded | Hold → Buy | 2023-05-04 |
Roth Capital | Upgraded | Neutral → Buy | 2023-01-30 |
SMBC Nikko | Reiterated | Outperform | 2022-07-28 |
William Blair | Upgraded | Market Perform → Outperform | 2022-01-12 |
Susquehanna | Reiterated | Positive | 2021-07-22 |
Rosenblatt | Reiterated | Buy | 2021-02-18 |
KeyBanc | Reiterated | Overweight | 2021-01-15 |
SunTrust Robinson Humphrey | Reiterated | Hold | 2020-07-30 |
Raymond James | Downgraded | Outperform → Market Perform | 2020-04-07 |
Bank of America | Reiterated | Underperform | 2019-08-02 |
Guggenheim | Downgraded | Buy → Neutral | 2019-05-13 |
PiperJaffray | Downgraded | Overweight → Neutral | 2018-08-01 |
Monness, Crespi, Hardt | Upgraded | Neutral → Buy | 2017-10-27 |
Monness Crespi Hardt | Upgraded | Neutral → Buy | 2017-10-27 |
Eight Capital | Upgraded | Neutral → Buy | 2017-05-03 |
BTIG | Downgraded | Buy → Neutral | 2017-04-27 |
BTIG Research | Downgraded | Buy → Neutral | 2017-04-27 |
Dundee | Reiterated | Neutral | 2016-10-17 |
Maxim Group | Reiterated | Hold | 2016-05-26 |
Macquarie | Reiterated | Outperform | 2016-05-18 |
Paradigm Capital | Reiterated | Buy | 2016-04-14 |
Pacific Crest | Upgraded | Sector Weight → Overweight | 2016-03-08 |
One row per institution, most recent rating